Oxazoles
![Medchemexpress LLC 4-(Benzo[d]oxazol-2-yl)aniline | 20934-81-0 | MFCD00453046 | 99.9% | 210.24 | C13H10N2O | 25 G](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000302850.png-250.jpg)
Medchemexpress LLC 4-(Benzo[d]oxazol-2-yl)aniline | 20934-81-0 | MFCD00453046 | 99.9% | 210.24 | C13H10N2O | 25 G
4-(Benzo[d]oxazol-2-yl)aniline (CAS 20934-81-0) is a small-molecule research compound reported to have antitumor activity, including inhibitory effects against mammary carcinoma cell lines. The product is analytically characterized with HPLC purity reported at 99.93% and has defined storage recommendations to preserve stability.
- High HPLC purity (99.93%) for reliable analytical work.
- Reported antitumor activity against mammary carcinoma cell lines.
- Molecular formula C13H10N2O; molecular weight 210.24.
- Recommended storage: 4°C, protect from light; in solvent: -80°C (up to 6 months), -20°C (1 month).
- Suitable as a research reagent for oncology and related studies.
FUJIFILM BIOSCIENCES INC Y-27632 GMP-compliant
Y-27632 is reagent for cell culture applications including human ES/iPS cell culture It enhances cell viability and reduces cell death during passaging and cryopreservation It is a selective and potent inhibitor of ROCK Rho-associated coiled-coil forming kinase/Rho binding kinase Y-27632 has a variety of activities including vascular smooth muscle contraction through the ROCK signaling Ki 140 nmol/L p160ROCK This product has been reported to suppress death of human ES/iPS cells at the time of cell dispersion and improves viability of the cells after cryopreservation This product complies with ICH-Q7 GMP for APIs as a raw material for commercial production of regenerative medicine products